Parkinson Disease Dementia
📧 Sign up to get email alerts when something new happens for Parkinson Disease Dementia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia [NA]
A clinical trial update for PERSEVERE, a study on peer mentor support and caregiver education for Lewy body dementia, currently active but n…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia [Phase 4]
Phase 4 clinical trial investigating the role of cholinergic degeneration in cognitive fluctuations in Lewy body dementias; currently recrui…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Community Outreach for Palliative Engagement -- Parkinson Disease [NA]
Status update for an ongoing University of Rochester clinical trial on community outreach and palliative engagement in Parkinson disease and…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
The University of Oregon completed the Family Caregiver Online Survey on dementia and swallowing difficulties; the snippet does not provide …
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments [Phase 1, Phase 2]
This clinical trial registry entry notes a Phase 1/2 trial evaluating tributyrin in people with Parkinson disease with cognitive impairment.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Parkinson's Disease and Movement Disorders Clinical Database
ClinicalTrials.gov entry for the Parkinson's Disease and Movement Disorders Clinical Database is currently recruiting and includes Parkinson…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Neurodegenerative Diseases [NA]
Clinical trial update shows that Sanmai Technologies is recruiting to evaluate transcranial ultrasound stimulation for neurological and cogn…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia [Phase 2]
Phase 2 clinical trial update evaluating ceftriaxone for efficacy and safety in patients with Parkinson's disease dementia; trial status is …
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease [NA]
Clinical trial update examining enhanced neuropsychological evaluation to enable earlier and more effective diagnosis of dementia in Parkins…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: PET Imaging in Parkinson Disease Dementia
Clinical trial update for a PET imaging study in Parkinson's disease dementia sponsored by Washington University School of Medicine; the stu…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Rural Dementia Caregiver Project [NA]
The Rural Dementia Caregiver Project by UCSF has completed and posted results evaluating caregiver outcomes (depression, stress, self-effica…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: A Study of Caregiver Connections Via Technology in Dementia [NA]
A Mayo Clinic study evaluates technology-assisted caregiver connections for people with dementia and related conditions. The study covers Al…
-
FDA approval · 2025-06-16FDA Approved: RIVASTIGMINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA has approved a supplemental application for rivastigmine from Zydus Pharmaceuticals USA Inc., indicating an approved change to the gener…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: SHARPEN - Parkinson's Disease Dementia [NA]
The SHARPEN trial for Parkinson disease dementia has been terminated and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies [Phase 2]
Phase 2 trial investigating imaging inflammation in patients with Parkinson's disease dementia and dementia with Lewy bodies has completed a…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial) [Phase 2]
The SHAPE Phase 2 trial evaluating ATH-1017 in Parkinson disease dementia and dementia with Lewy bodies was terminated, and results have bee…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones [NA]
A terminated University of Michigan clinical trial evaluated brain metabolism of small-chain fatty acids using ketone-based therapy in Parki…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Monitoring Anti-Dementia Drugs by Serum Levels [Phase 4]
Phase 4 trial update evaluating serum-level monitoring for anti-dementia drugs in dementia patients, with results posted.
-
FDA approval · 2025-01-22FDA Approved: RIVASTIGMINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for rivastigmine by Mylan Pharmaceuticals Inc. The approval indicates a modification to the product'…
-
FDA approval · 2025-01-22FDA Approved: RIVASTIGMINE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for rivastigmine from Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Sing for Your Saunter - Dementia Supplement [NA]
A completed clinical trial evaluating a dementia supplement for Parkinson's disease and Parkinson's disease dementia has posted its results.
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders [Phase 2]
Phase 2 clinical trial update reporting completed status and posted results for clenbuterol (CST-103) co-administered with nadolol (CST-107)…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: ADDIA Proof-of-Performance Clinical Study
ADDIA Proof-of-Performance clinical study by Amoneta Diagnostics SAS has completed; the update lists multiple neurodegenerative conditions a…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Innovations in Dementia Empowerment and Action [NA]
A dementia-focused clinical trial conducted by the University of Washington has completed and posted its results in July 2024. The study spa…
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: To Evaluate the Safety of DBS in Patients With Primary Parkinson's Disease [NA]
A clinical trial registry entry for a study evaluating the safety of deep brain stimulation in patients with Parkinson's disease. Parkinson'…